At a glance
- Originator Wyeth
- Class Antidepressants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 16 Oct 2009 Pfizer acquires Wyeth
- 18 Oct 2000 Profile reviewed but no significant changes made
- 21 Jul 1999 No-Development-Reported for Alzheimer's disease in Italy (PO)